Advances in Esophagogastric Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 30 November 2024 | Viewed by 1072
Special Issue Editors
Interests: esophageal cancer
Interests: cancer cachexia; muscle wasting; esophagogastric cancer; surgery; clinical trials
Special Issues, Collections and Topics in MDPI journals
Interests: esophageal cancer
Interests: esophageal cancer
Special Issue Information
Dear Colleagues,
We are launching a Special Issue of Cancers entitled “Advances in Esophageal Cancer Treatment”. Our aim is to present an overview of the current debates in the treatment of esophageal cancer and to investigate the future impact of the newly introduced advances in the field.
This Special Issue will focus on the development of the robot-assisted approach and diagnostic tools with the implementation of deep learning, radiomics and pathomics. At the same time, our goal is to enlighten the role of immunotherapy in the curative and palliative treatment of esophageal cancer, the current and future investigations on the genetics of the disease, organ-sparing treatments, the therapeutic approach to oligometastatic disease, the comparison between the proton versus photon beam radiation, and the advantages and limitations of follow-up protocols after curative treatment. The indicators for quality of care in esophageal malignancy, along with the evaluation of the existing databases from high-volume centers worldwide, stand among this Special Issue’s focuses.
You are highly welcome to submit an original article/review/meta-analysis to this Special Issue.
Dr. B.P.L. (Bas) Wijnhoven
Dr. Richard Skipworth
Dr. Pieter Van der Sluis
Dr. Tania Triantafyllou
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- gastric cancer
- esophageal cancer
- esophagectomy
- chemotherapy
- radiotherapy
- immunotherapy
- perioperative management
- artificial intelligence